Literature DB >> 17826032

CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice.

Yuji Nagayama1, Ichiro Horie, Ohki Saitoh, Mami Nakahara, Norio Abiru.   

Abstract

NOD-H2(h4) mice, which express I-A(k) on the NOD background, spontaneously develop autoimmune thyroiditis, a model of Hashimoto thyroiditis in humans, by adding iodide in the drinking water. Parental NOD mice have previously been shown to have intrinsic numerical abnormalities in peripheral lymphocytes and lymphocyte subpopulations such as CD4(+)CD25(+) naturally occurring regulatory T cells (Treg). Therefore we first investigated whether the similar abnormalities exist in NOD-H2(h4) mice. We observed that, compared with other non-autoimmune disease prone BALB/c and C57BL/6 mice, NOD-H2(h4) mice have lower numbers of splenocytes, CD3(+)T, CD4(+)T and CD8(+)T cells but the ratios of Treg to CD4(+)T cells were comparable. Increasing the numbers of peripheral lymphocytes by Complete Freund's Adjuvant immunization or splenocyte transfer did not affect development of thyroiditis, indicating that lymphopenia does not play a critical role in the pathogenesis of thyroiditis. We next examined the significance of Treg by depleting this lymphocyte subset with anti-CD25 antibody. Treg depletion, performed 4days before the administration of NaI water for 8 weeks, significantly exacerbated thyroiditis (p<0.01). Anti-thyroglobulin antibody titers also increased by Treg depletion (p<0.01) without changing the IgG2b to IgG1 ratios. In addition, expression levels of mRNA for IFN-gamma and IL-4 were enhanced in parallel. However, T(4) levels were similar between antibody-treated and untreated groups. Additional anti-CD25 administration at 3 weekly intervals did not influence these results. These data, together with previous studies on other mouse models of inducible thyroiditis and Graves' disease, indicate the role played by Treg in keeping anti-thyroid autoimmune reaction in check in experimental autoimmune thyroid diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826032     DOI: 10.1016/j.jaut.2007.07.008

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  23 in total

1.  Combination of rapamycin and IL-2 increases de novo induction of human CD4(+)CD25(+)FOXP3(+) T cells.

Authors:  S Alice Long; Jane H Buckner
Journal:  J Autoimmun       Date:  2008-03-03       Impact factor: 7.094

2.  MicroRNA-326 contributes to autoimmune thyroiditis by targeting the Ets-1 protein.

Authors:  Na Zhao; Hongjin Zou; Jing Qin; Chenling Fan; Yongping Liu; Shuo Wang; Zhongyan Shan; Weiping Teng; Yushu Li
Journal:  Endocrine       Date:  2017-11-27       Impact factor: 3.633

3.  Regulatory T cells in B-cell-deficient and wild-type mice differ functionally and in expression of cell surface markers.

Authors:  Jason S Ellis; Helen Braley-Mullen
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

4.  Transient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adults.

Authors:  Shiguang Yu; Jason S Ellis; Robert Dunn; Marilyn R Kehry; Helen Braley-Mullen
Journal:  Int Immunol       Date:  2012-01-31       Impact factor: 4.823

5.  Recombinant expression of homodimeric 660 kDa human thyroglobulin in soybean seeds: an alternative source of human thyroglobulin.

Authors:  Rebecca Powell; Laura C Hudson; Kevin C Lambirth; Diane Luth; Kan Wang; Kenneth L Bost; Kenneth J Piller
Journal:  Plant Cell Rep       Date:  2011-03-08       Impact factor: 4.570

6.  Reduced effectiveness of CD4+Foxp3+ regulatory T cells in CD28-deficient NOD.H-2h4 mice leads to increased severity of spontaneous autoimmune thyroiditis.

Authors:  Jason S Ellis; So-Hee Hong; Habib Zaghouani; Helen Braley-Mullen
Journal:  J Immunol       Date:  2013-10-04       Impact factor: 5.422

Review 7.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 8.  Etiopathogenesis of primary biliary cirrhosis.

Authors:  Ana Lleo; Pietro Invernizzi; Ian-R Mackay; Harry Prince; Ren-Qian Zhong; M-Eric Gershwin
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

9.  Exacerbation of Autoimmune Thyroiditis by CTLA-4 Blockade: A Role for IFNγ-Induced Indoleamine 2, 3-Dioxygenase.

Authors:  Rajni Sharma; Giulia Di Dalmazi; Patrizio Caturegli
Journal:  Thyroid       Date:  2016-07-22       Impact factor: 6.568

Review 10.  Toxicology of autoimmune diseases.

Authors:  K Michael Pollard; Per Hultman; Dwight H Kono
Journal:  Chem Res Toxicol       Date:  2010-03-15       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.